Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis

Damianos G. Kokkinidis(Memorial Hospital of South Bend), Ehrin J. Armstrong(University of Denver), Dharam J. Kumbhani(Southwestern Medical Center), Omar Jawaid(Denver VA Medical Center), Sahil A. Parikh(NewYork–Presbyterian Hospital), Jay Giri(Hospital of the University of Pennsylvania), Anil Kumar Jonnalagadda(MedStar Washington Hospital Center), Eric A. Secemsky(Beth Israel Deaconess Medical Center), Angelos Arfaras-Melainis(Jacobi Medical Center), Stefanos Giannopoulos(Denver VA Medical Center), Ioannis Katsaros(Royal Free London NHS Foundation Trust)
Vascular Medicine
January 22, 2020
10.1177/1358863x19894055
Cited by 77

Related Papers

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
|Metabolism|2020|901
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
|Circulation|2024|549
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity
|JAMA Cardiology|2019|418
Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
|Journal of the American Heart Association|2014|243